Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters

cafead

Administrator
Staff member
  • cafead   Nov 20, 2023 at 10:22: AM
via Carmot Therapeutics on Friday filed for an initial public offering (IPO), banking on its pipeline of GLP-1 agonists and the multibillion-dollar potential of the obesity market.

article source